Black multi-pinhole occluder
9 inch double ended with one end black and the other end with 49 holes
Double Ended Occluders
49 pinholes, black
Medicine Products:(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3(Date:8/19/2008)...19 /- VION,PHARMACEUTICALS,...had,entered into an agreement with the Dutch-Belgi... (the "HOVON") to conduct a clinical trial of,laro... remission-induction,therapy in patients aged 18-6...emia (AML) and high-risk myelodysplasia (MDS)., A...
(Date:8/18/2008)...ewswire/ -- The next time you consider popping a,p... worth counting sheep,instead. A senior psychiatri..., Calif. has found evidence that taking sleeping p...r., Daniel F. Kripke, M.D.,s article, based on a ...d cancer, has just been published in the Journal,o...
(Date:8/18/2008)...st 18 /- Oramed,Pharmaceuti...m ), a developer,of oral delivery systems, announc...tudy to Assess the Safety, Pharmacokinetics (PK) a...ulations in Healthy,Subjects," has been chosen for...of the European Association for the Study of Diabe...
(Date:8/18/2008)...l trial currently in Phase I -, PRINCETON, N.J. a...peutics Inc., a clinical stage biotechnology compa... against life-threatening and life-altering,infect...ent No. 7,371,772,B2 by the U.S. Patent and Tradem...tagonist currently in Phase I development for the ...
Breaking Medicine Technology:Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Prescription Sleeping Pill Use Tied to Cancer 2Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Will botox be the aspirin of the 21st century 3F 14566 1Will botox be the aspirin of the 21st century 3F 14566 2Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 1Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 2Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 3New England Technology Foundation Announces Connecting for Childrens Charities 2008 Event 14560 1New England Technology Foundation Announces Connecting for Childrens Charities 2008 Event 14560 2Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 14557 1Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 14557 2Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 14557 3Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 14557 4...ated with Satraplatin Demonstrated Statistically,S...sponse Rates, BERLIN, March 22, 2007 /PRNewswire-F...AG today announced additional data from,the double...nal,trial, the SPARC trial (Satraplatin and Predni...ed today at the 22nd Annual,European Association o...
... S.C., March 23, 2007 /PRNewswire/ -- Researchers ... have announced the,results of a two-year study, w...to VNS (Vagus Nerve Stimulation),Therapy(TM) in pa...The study, of which Mark S. George, M.D., MUSC Dis...Neurosciences is a lead,author, will appear in the...
Other Medicine Technology:Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 2Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 4Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 5Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 6Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 7MUSC Research Offers Hope for Those Resistant to Depression,Treatment 2